High pathological response rate with neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and levo-folinic acid (LFA) + RT in poor-risk locally advanced rectal cancer (LARC): Results of a phase II study with dynamic evaluation by FDG-PET scan

Antonio Avallone,D. Lastoria,Paolo Delrio,C. Guida,Fabiana Tatangelo,P. Marone,A. Petrillo,Alfredo Budillon,Giuseppe Lucio Cascini,P. Comella

High pathological response rate with neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5-fluorouracil (FU) and levo-folinic acid (LFA) + RT in poor-risk locally advanced rectal cancer (LARC): Results of a phase II study with dynamic evaluation by FDG-PET scan

2005

Antonio Avallone
D. Lastoria
Paolo Delrio
C. Guida
Fabiana Tatangelo
P. Marone
A. Petrillo
Alfredo Budillon
Giuseppe Lucio Cascini
P. Comella

3584 Background: Preoperative chemo-radiation (CT-RT) in LARC has been shown to improve prognosis of patients (pts) in whom a total (TRG1) or subtotal (TRG2) pathologic tumor regression is achieved...

Keywords:

Folinic acid
Fluorouracil
Physical therapy
Phases of clinical research
Colorectal cancer
Raltitrexed
Cancer research
Surgery
Medicine
Oxaliplatin
locally advanced
poor risk
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations